D.Western Therapeutics Institute, Inc. Logo

D.Western Therapeutics Institute, Inc.

Biotech firm discovering and licensing drug candidates, focusing on kinase inhibitors.

4576 | T

Overview

Corporate Details

ISIN(s):
JP3548740004
LEI:
Country:
Japan
Address:
名古屋市中区錦一丁目18番11号
Sector:
Mining and quarrying
Industry:
Mining of non-ferrous metal ores

Description

D.Western Therapeutics Institute, Inc. is a university-originated biotechnology venture focused on drug discovery and development. The company aims to create innovative and more effective drugs for patients worldwide by leveraging its core technology, which includes a proprietary compound library and specialized expertise in inhibitors, particularly protein kinases. Its business model centers on discovering and developing novel drug candidates before out-licensing them to larger pharmaceutical companies for late-stage clinical trials and commercialization. The company's development pipeline includes therapeutic drugs for various conditions, with a known focus in areas such as ophthalmology.

Unlock This Filing & Millions More

You're one step away from the data you need. Create a free account to instantly view this filing and get access to powerful research tools.

Filings

You have of free filing views remaining. Upgrade for unlimited access.
Quick Filters:

Filters

Clear
Bulk Actions:
Date Filing Language Size Actions
2025-08-14 08:45
Interim Report
半期報告書-第28期(2025/01/01-2025/12/31)
Japanese 175.2 KB
2025-08-14 08:45
Report Publication Announcement
確認書
Japanese 8.2 KB
2025-07-15 08:30
Registration Form
有価証券届出書(組込方式)
Japanese 540.8 KB
2025-03-26 01:26
Post-Annual General Meeting Information
臨時報告書
Japanese 25.8 KB
2025-03-25 07:31
Registration Form
確認書
Japanese 8.2 KB
2025-03-25 07:30
Governance Information
内部統制報告書-第27期(2024/01/01-2024/12/31)
Japanese 21.5 KB
2025-03-25 07:30
Annual Report
有価証券報告書-第27期(2024/01/01-2024/12/31)
Japanese 1.1 MB
2025-01-16 07:34
Regulatory News Service
臨時報告書
Japanese 18.4 KB
2025-01-10 02:55
Major Shareholding Notification
臨時報告書
Japanese 21.1 KB
2024-08-09 08:35
Report Publication Announcement
確認書
Japanese 8.2 KB
2024-08-09 08:34
Interim Report
半期報告書-第27期(2024/01/01-2024/12/31)
Japanese 219.2 KB
2024-06-07 08:31
Regulatory News Service
臨時報告書
Japanese 19.3 KB
2024-05-17 08:01
Registration Form
有価証券届出書(組込方式)
Japanese 328.7 KB
2024-05-13 08:32
Report Publication Announcement
確認書
Japanese 8.1 KB
2024-05-13 08:31
Quarterly Report
四半期報告書-第27期第1四半期(2024/01/01-2024/03/31)
Japanese 135.5 KB

Automate Your Workflow. Get a real-time feed of all D.Western Therapeutics Institute, Inc. filings delivered via API.

Explore Data Feeds →

Market Data

Market Data Not Available

Financials & KPIs

No data available

Unlock Full Financials for D.Western Therapeutics Institute, Inc.

This data is available as part of our premium data solutions. Contact our team for access.

Need More History? Access decades of standardized financials for D.Western Therapeutics Institute, Inc. via our API.

Get Historical Data →

Insider Transactions

Date Insider Name Position Type Shares Value
No insider transactions recorded for this company.

Peer Companies

Nuvectis Pharma, Inc. Logo
Clinical-stage biopharma developing precision medicines for serious oncological conditions.
United States of America
NVCT
Nykode Therapeutics ASA Logo
Developing novel immunotherapies and vaccines for cancer with its antigen-targeting platform.
Norway
NYKD
Ocugen, Inc. Logo
Develops gene/cell therapies and vaccines, specializing in blindness and public health.
United States of America
OCGN
Oculis Holding AG Logo
Clinical-stage biopharma developing non-invasive eye drops for sight-threatening diseases.
Switzerland
OCS
OKYO Pharma Ltd Logo
Biopharma developing novel drugs for inflammatory eye diseases and neuropathic corneal pain.
United States of America
OKYO
OLIPASS CORPORATION Logo
Biotech firm developing RNA therapeutics for diseases with its proprietary OPNA platform.
South Korea
244460
A technology platform for pharma/biotech to discover therapeutic antibodies via transgenic animals.
United States of America
OABIW
Oncocross Co.,Ltd. Logo
AI-powered biotech accelerating drug development for cancer and rare diseases.
South Korea
382150
Onconic Therapeutics Inc. Logo
Develops novel drugs for cancer and GI diseases, including a next-gen acid blocker.
South Korea
476060
OncoTherapy Science, Inc. Logo
Develops targeted cancer therapies and provides TCR repertoire analysis services.
Japan
4564

Talk to a Data Expert

Have a question? We'll get back to you promptly.